Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy
Quynh Nguyen,*,1 Kenji Rowel Q Lim,*,1 Toshifumi Yokota,1,21Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada; 2The Friends of Garrett Cumming Research & Muscular Dystrophy Canada, HM Toupin Neurological Science R...
Main Authors: | Nguyen Q, Lim KRQ, Yokota T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-07-01
|
Series: | The Application of Clinical Genetics |
Subjects: | |
Online Access: | https://www.dovepress.com/current-understanding-and-treatment-of-cardiac-and-skeletal-muscle-pat-peer-reviewed-article-TACG |
Similar Items
-
Eteplirsen in the treatment of Duchenne muscular dystrophy
by: Lim KRQ, et al.
Published: (2017-02-01) -
Pharmacological Profile of Viltolarsen for the Treatment of Duchenne Muscular Dystrophy: A Japanese Experience
by: Roshmi RR, et al.
Published: (2021-12-01) -
Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges
by: Yusuke Echigoya, et al.
Published: (2018-12-01) -
CRISPR Therapeutics for Duchenne Muscular Dystrophy
by: Esra Erkut, et al.
Published: (2022-02-01) -
Challenges and future perspective of antisense therapy for spinal muscular atrophy: A review
by: Zorica Nakevska, et al.
Published: (2023-06-01)